A.
Cystic fibrosis
B.
Maple syrup disease
C.
D.
Bilirubin conjugation defects
Answer is CysticFibrosis
Reference-Biochemical
Case Histories [new chapter added in Harper 28th edition]
A 1-year-old girl, an only child
of Caucasian background, was brought to the clinic at the Hospital for Sick
Childrenby her mother. She had been feverish for the past 24 h and was coughing
frequently. The mother stated that herdaughter had experienced three attacks of "bronchitis"
since birth, each of which had been treated with antibioticsby their family
physician. The mother had also noted that her daughter had been passing somewhat
bulky, foulsmellingstools for the
past several months and was not gaining weight as expected. In view of the
history ofpulmonary and gastrointestinal problems, the attending physician
suspected that the patient might have CF,
although no family history of
this condition was elicited.
Laboratory Findings
Chest x-rays showed signs
consistent with bronchopneumonia. Culture of sputum revealed predominantlyPseudomonas
aeruginosa. Fecal fat was increased.
A quantitative pilocarpine iontopheresis sweat test wasperformed, and the sweat
Cl– was 70
mmol/L (>60 mmol/L is abnormal); the test was repeated a week later
withsimilar results.
Treatment
The child was given an
appropriate antibiotic and referred to the cystic fibrosis clinic for
further care. Acomprehensive program was instituted to look after all
aspects of her health, including psychosocialconsiderations. She was started on
a pancreatic enzyme preparation (given with each meal) and placed on ahigh-calorie
diet supplemented with multivitamins and vitamin E. Postural
drainage was begun for the thickpulmonary secretions. Subsequent infections
were treated promptly with appropriate antibiotics and with anaerosolized
recombinant preparation of human DNase that digests the DNA of
microorganisms present in therespiratory tract. At age 6 years, she had grown
normally, had been relatively free of infection for a year, wasattending school
and making satisfactory progress. Serious chronic cases of CF in which the
lungs are severelycompromised are candidates for lung transplants, although
the effiacy of this treatment has been challengedrecently.
Research on gene therapy for
CF is under examination (eg, using recombinant viruses encoding the
CFTRprotein). Another line of research is investigating whether small
molecules can be found for clinical use that helpabnormally folded CFTR
molecules re-fold into at least partially active molecules.
Discussion
CF is a prevalent and
usually serious genetic disease among whites in North America. It affects
approximately1:2500 individuals and is inherited as an autosomal recessive disease;
about one person in 25 is a carrier. It is adisease of the exocrine glands, with
the respiratory and gastrointestinal tracts being most affected.
Adiagnostic hallmark is the presence of high amounts of NaCl in sweat, reflecting
an underlying abnormality inexocrine gland function (see below). Pilocarpine
iontophoresis has generally been used to allow collection ofsufficient
amounts of sweat for analysis. Iontophoresis is a process by which drugs are
introduced into the body (inthis case the skin) via use of an electrical
current. Its use is diminishing as the availability of specific genetic probes
increases.
The classic presentation of
CF is that of a young child with a history of recurrent pulmonary infection and
signs ofexocrine insufficiency (eg, fatty, bulky stools due to a lack of
pancreatic lipase), as in the present case. However,the disease is clinically
heterogeneous, which at least partly reflects heterogeneity at the
molecular level Approximately 15% of patients may have sufficient pancreatic
function to be classified as "pancreaticsufficient."
For reasons related to
abnormalities in Cl– and Na+ transport the
pancreatic ducts and the ducts ofcertain other exocrine glands become filled
with viscous mucus, which leads to their obstruction. This mucus
inalso present in the bronchioles, leading to their obstruction; this
favors the growth of certain bacteria (eg,Staphylocococu aureus and P
aeruginosa ) that cause recurrent bronchopulmonary infections, eventuallyseriously
compromising lung function. In turn, the pulmonary disease can lead to right
ventricular hypertrophy andpossible heart failure. Patients usually die of pulmonary
infection or heart failure. In recent years, morepatients have been
living into their 30s and later, as the condition is now diagnosed earlier and
appropriatecomprehensive therapy started. Sometimes, problems due to lack of
pancreatic secretions can be present at birth,
the infants presenting with intestinal obstruction
due to very thick meconium (meconium ileus). Other patientsless severely
affected, may not be diagnosed until they are in their teens or later. CF also
affects the genital tractand most males and many females are infertile
No comments:
Post a Comment